Abnormal spontaneous activity on needle electromyography in myasthenia gravis
Deepa Kannaditharayil(Montefiore Medical Center), Steven Herskovitz(Montefiore Medical Center), Phyllis Bieri(Albert Einstein College of Medicine), Volkan Granit(Biohaven Pharmaceuticals (United States)), Fabreena Napier(Montefiore Medical Center)
Cited by 8
Related Papers
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
|The Lancet Neurology|2023|255
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS
|Neurology|2020|201
Venous Thromboembolism Prophylaxis after Head and Spinal Trauma: Intermittent Pneumatic Compression Devices Versus Low Molecular Weight Heparin
|World Journal of Surgery|2004|149